PAD 0193 (Indomethacin extended release 75 mg)
Pill with imprint PAD 0193 is White, Capsule-shape and has been identified as Indomethacin extended release 75 mg. It is supplied by Paddock Laboratories, Inc..
Indomethacin is used in the treatment of gout, acute; back pain; cluster headaches; ankylosing spondylitis; bartter syndrome (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Indomethacin 75 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for PAD 0193
- PAD 0193
- 75 mg
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Paddock Laboratories, Inc.
- Inactive Ingredients:
- carboxymethylcellulose sodium
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
More about indomethacin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 148 Reviews – Add your own review/rating
- Drug class: nonsteroidal anti-inflammatory agents
- Indomethacin Capsules
- Indomethacin Sustained-Release Capsules
- Indomethacin Injection
- Indomethacin Suppositories
- ... +4 more
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.